30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Garheng Kong

Insider profile

Currently holds positions in Alimera Sciences Inc, Labcorp Holdings Inc and Strongbridge Biopharma plc

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return 44% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Alimera Sciences Inc Oct. 1, 2012 -
Independent Director Labcorp Holdings Inc Dec. 1, 2013 -
Lead Independent Director Strongbridge Biopharma plc Nov. 18, 2019 -
Independent Director Melinta Therapeutics Inc Jan. 1, 2016 - June 11, 2019
Independent Chairman of the Board Ocugen Inc July 1, 2012 - Feb. 22, 2019
Independent Chairman of the Board Melinta Therapeutics Inc Nov. 1, 2008 - Jan. 1, 2016

Garheng Kong's trades of Venus Concept Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-12-17 2021-12-15 B Purchase
29,717 +21.3%
161.03
US$4,663,823
29,717 +21.3% 161.03 US$4,663,823
2019-02-19 2019-02-19 B Purchase
62,474 -2.3%
255.23
US$1,453,036
62,474 -2.3% 255.23 US$1,453,036